Hui Wang

Hui Wang is the founder of Jiangsu Highlight Equity Investment Management Co. Ltd., founded in 2014, holding the title of Founding Partner.
Current jobs include Chief Executive Officer at Highlight Capital Fund since 2014; Director at Suzhou Kintor Pharmaceuticals, Inc.; Director at Biotheus, Inc.; Director at WinnTi Medical Technology (Shanghai) Co., Ltd.; and Senior Partner at CDH Venture Partners LP since 2009.
Former jobs include Vice Chairman at Juva (Tianjin) Medical Technology Co., Ltd.; Chairman-Supervisory Board at Chengdu Angel Medical Holdings Co., Ltd.; Non-Executive Director at Viva Biotech Holdings from 2024 to 2026; Independent Director at ImageneBio, Inc. from 2025 to 2026; Non-Executive Director at Zylox-Tonbridge Medical Technology Co., Ltd. from 2015 to 2018 and again from 2020 to 2025; Director at Genfleet Therapeutics (Shanghai), Inc.; General Partner at CDH Investments from 2009 to 2014; and Principal at Becton, Dickinson & Co. Education includes graduate degree from New York University in 1998; undergraduate degree from the University of Science & Technology of China in 1996; MBAistration from London Business School in 2007; and an undergraduate degree from London Business School.